(Q33800438)

English

Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

0 references

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

author name string

Albert Oriol

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Susana Vives

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Jesús-María Hernández-Rivas

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Mar Tormo

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Inmaculada Heras

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Concepción Rivas

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Concepción Bethencourt

7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Federico Moscardó

8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Javier Bueno

9

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Carlos Grande

10

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Eloy del Potro

11

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Ramon Guardia

12

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Salut Brunet

13

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Juan Bergua

14

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Teresa Bernal

15

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Maria-José Moreno

16

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Carlota Calvo

17

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Pilar Bastida

18

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Evarist Feliu

19

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Josep-Maria Ribera

20

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Programa Español de Tratamiento en Hematologia Group

21

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

9 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

95

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

589-596

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Adolescents with acute lymphoblastic leukaemia: emerging from the shadow of paediatric and adult treatment protocols

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857188

28 July 2018

High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857188

28 July 2018

Haemopoietic stem cell transplantation for acute lymphoblastic leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857188

28 July 2018

Salvage therapy for refractory or relapsed acute lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857188

28 July 2018

Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857188

28 July 2018

352. Note: Conservatism of the Approximation Σ(O - E) 2 /E in the Logrank Test for Survival Data or Tumor Incidence Data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857188

28 July 2018

Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857188

30 October 2018

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857188

30 October 2018

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857188

30 October 2018

Treatment of acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857188

30 October 2018

Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857188

30 October 2018

Clinical effect of imatinib added to intensive combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857188

30 October 2018

Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857188

30 October 2018

Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857188

30 October 2018

Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857188

30 October 2018

A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857188

30 October 2018

Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857188

30 October 2018

Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/20145276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20145276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of adults with acute lymphoblastic leukaemia in first bone marrow relapse: results of the ALL R-87 protocol

1 reference

https://pubmed.ncbi.nlm.nih.gov/20145276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of relapsed adult acute lymphoblastic leukemia with fludarabine and cytosine arabinoside followed by granulocyte colony-stimulating factor (FLAG-GCSF)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20145276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology

1 reference

https://pubmed.ncbi.nlm.nih.gov/20145276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary refractory and relapsed adult acute lymphoblastic leukemia: characteristics, treatment results, and prognosis with salvage therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20145276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20145276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20145276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20145276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3324/HAEMATOL.2009.014274

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33800438&oldid=1988817316"